Huron announced a key executive expansion today. The company also announced that Dr. L. Thomas Richards has been elected to the board of directors, effective July 23, 2026. This strategic move directly aligns with the company’s ongoing board refreshment initiative. The addition also expands the company’s governing body to a total of 10 members. Huron is looking to benefit from Dr. Richards’ vast experience in life sciences, healthcare innovation and corporate governance.
Executive Background & Governance Expertise
Dr. Richards recently chaired the board of directors at executive search firm WittKieffer. Previously, he served as Interim Chief Executive Officer of One Biomed and Chief Executive Officer of TessArae. Furthermore, he advises private equity and venture capital investors across the life sciences industry. He also worked as Senior Advisor to Metis Genetics, One Biomed, and Nanomix. Additionally, Dr. Richards practiced academic emergency medicine at Stanford University and the University of California, San Francisco.
Meanwhile, earlier in his career, Dr. Richards worked as an investment banker in M&A groups. He advised prominent financial organizations, including Lazard Frères, UBS, and SG Cowen. Huron will benefit from his past public board experience at Cowen Group, Inc. Moreover, he holds degrees from Yale University, the University of Sydney, and Harvard Medical School. Today, he serves on non-profit boards for The World Telehealth Initiative and Surfrider Foundation. Ultimately, Huron gains an accomplished executive leader to drive sustainable shareholder value creation.
“We are pleased to welcome Tom to Huron’s Board of Directors,” said Hugh Sawyer, non-executive chairman of the Huron board. “Tom brings a unique combination of senior management, board leadership, and capital markets expertise across his roles as an investment banker, life sciences executive, physician, and board director. His global perspective, and expertise in evaluating and adopting new innovative technologies, and extensive governance experience in professional services will be a strong asset to our Board as we continue to advance Huron’s growth strategy to create long-term value for our shareholders.”
Meanwhile, Dr. Richards expressed enthusiasm about supporting the organization’s strategic vision.
“I am honored to serve on Huron’s Board of Directors,” said Dr. L. Thomas Richards. “I look forward to partnering with my fellow directors and Huron’s management team to build on the firm’s strong momentum, advance its long-term strategy, and help create lasting value for its clients, people, and shareholders.”
For more stories on technology leaders shaping the future of enterprise solutions, visit our CXO Insiders.
Source: Businesswire
